Pacylex Pharmaceuticals Publishes a New Myristoylation Inhibitor Mechanism of Anti-Cancer Activity in Molecular Cancer Therapeutics ...

The regulation and remodeling of the tumor microenvironment (TME) are closely associated with how cancers typically progress ...

Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address oncogenic and immune dysregulation that drive cancer, ...

For many years, scientists have known that genetic variants, or differences in DNA code across people, play some role in ...

Former Eli Lilly Research Fellow Jeremy R. Graff, Ph.D., appointed as President and Chief Development Officer to lead the Company’s clinical ...

TARRYTOWN, NY, USA I October 1, 2024 I Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address oncogenic and ...

A group of essential signaling molecules known as the Wnt pathway emerged early in the evolution of multicellular life.

A group of essential signaling molecules known as the Wnt pathway emerged early in the evolution of multicellular life. Scientists have been studying Wnt actions for four decades to comprehend its ...

Cellular signal boosters use big antennas to improve coverage in your home or car. These are the top signal boosters for apartments, houses, and vehicles. I’m one of PCMag’s mobile analysts.

The deal was announced on Roche's Pharma Day, where the Swiss Big Pharma—which owns Genentech—also disclosed (PDF) the acquisition of Wnt signaling ... the Wnt pathway could be very promising ...